Department of Clinical, Neuro- and Developmental Psychology, Section Clinical Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute Amsterdam, Amsterdam, the Netherlands.
JAMA Psychiatry. 2019 Jul 1;76(7):682-690. doi: 10.1001/jamapsychiatry.2019.0219.
IMPORTANCE: Globally, access to evidence-based psychological treatment is limited. Innovative self-help methods using smartphone applications and low-cost virtual reality have the potential to significantly improve the accessibility and scalability of psychological treatments. OBJECTIVE: To examine the effectiveness of ZeroPhobia, a fully self-guided app-based virtual reality cognitive behavior therapy (VR CBT) using low-cost (cardboard) virtual reality goggles compared with a wait-list control group and to determine its user friendliness. DESIGN, SETTING, AND PARTICIPANTS: In a single-blind randomized clinical trial, participants were enrolled between March 24 and September 28, 2017, and randomly assigned (1:1) by an independent researcher to either VR CBT app or a wait-list control group. A total of 193 individuals aged 18 to 65 years from the Dutch general population with acrophobia symptoms and access to an Android smartphone participated. The 6 animated modules of the VR-CBT app and gamified virtual reality environments were delivered over a 3-week period in participants' natural environment. Assessments were completed at baseline, immediately after treatment, and at 3-month follow-up. Analysis began April 6, 2018, and was intention to treat. INTERVENTION: Self-guided app-based VR CBT. MAIN OUTCOMES AND MEASURES: The primary outcome measure was the Acrophobia Questionnaire. The hypothesis was formulated prior to data collection. RESULTS: In total, 193 participants (129 women [66.84%]; mean [SD] age, 41.33 [13.64] years) were randomly assigned to intervention (n = 96) or a wait-list control group (n = 97). An intent-to-treat analysis showed a significant reduction of acrophobia symptoms at posttest at 3 months for the VR-CBT app compared with the controls (b = -26.73 [95% CI, -32.12 to -21.34]; P < .001; d = 1.14 [95% CI, 0.84 to 1.44]). The number needed to treat was 1.7. Sensitivity and robustness analysis confirmed these findings. Pretreatment attrition was 22 of 96 (23%) because of smartphone incompatibility. Of the 74 participants who started using the VR-CBT app, 57 (77%) completed the intervention fully. CONCLUSIONS AND RELEVANCE: A low-cost fully self-guided app-based virtual reality cognitive behavioral therapy with rudimentary virtual reality goggles can produce large acrophobia symptom reductions. To our knowledge, this study is the first to show that virtual reality acrophobia treatment can be done at home without the intervention of a therapist. TRIAL REGISTRATION: Trialregister.nl identifier: NTR6442.
重要性:在全球范围内,获得基于证据的心理治疗的机会有限。使用智能手机应用程序和低成本虚拟现实的创新自助方法有可能显著提高心理治疗的可及性和可扩展性。 目的:研究 ZeroPhobia 的有效性,这是一种完全自我指导的基于应用程序的虚拟现实认知行为疗法 (VR CBT),使用低成本(纸板)虚拟现实护目镜,与候补名单对照组进行比较,并确定其用户友好性。 设计、设置和参与者:在一项单盲随机临床试验中,参与者于 2017 年 3 月 24 日至 9 月 28 日之间招募,并由独立研究人员以 1:1 的比例随机分配到 VR CBT 应用程序或候补名单对照组。共有 193 名年龄在 18 至 65 岁之间、来自荷兰普通人群的恐高症患者和可访问 Android 智能手机的患者参加了研究。该 VR-CBT 应用程序的 6 个动画模块和游戏化的虚拟现实环境在参与者的自然环境中在 3 周内进行了传递。评估在基线、治疗后立即和 3 个月随访时进行。分析于 2018 年 4 月 6 日开始,采用意向治疗。 干预措施:自我指导的基于应用程序的 VR CBT。 主要结果和措施:主要结局测量是恐高症问卷。假设在数据收集之前提出。 结果:共有 193 名参与者(129 名女性 [66.84%];平均 [标准差]年龄,41.33 [13.64] 岁)被随机分配到干预组(n=96)或候补名单对照组(n=97)。意向治疗分析显示,与对照组相比,VR-CBT 应用程序在 3 个月时的恐高症症状显著降低(b=-26.73[95%CI,-32.12 至-21.34];P<.001;d=1.14[95%CI,0.84 至 1.44])。需要治疗的人数为 1.7。敏感性和稳健性分析证实了这些发现。由于智能手机不兼容,治疗前有 22 名(96 名中的 23%)参与者退出。在开始使用 VR-CBT 应用程序的 74 名参与者中,有 57 名(77%)完成了全部干预。 结论和相关性:使用基本虚拟现实护目镜的低成本完全自我指导的基于应用程序的虚拟现实认知行为疗法可以显著降低恐高症症状。据我们所知,这项研究首次表明,虚拟现实恐高症治疗可以在家中进行,而无需治疗师的干预。 试验注册:Trialregister.nl 标识符:NTR6442。
Proc Natl Acad Sci U S A. 2025-5-20
Front Public Health. 2025-4-10
Front Psychiatry. 2024-12-18
NPJ Digit Med. 2024-12-18
J Anxiety Disord. 2018-6-21
J Anxiety Disord. 2018-7-17
Med J Aust. 2017-4-3
Clin Epidemiol. 2017-3-15